Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144–64. https://doi.org/10.1093/ecco-jcc/jjy113.

Article  PubMed  Google Scholar 

Lee M, Chang EB. Inflammatory bowel diseases and the microbiome: searching the crime scene for clues. Gastroenterology. 2021;160:524–37. https://doi.org/10.1053/j.gastro.2020.09.056.

Article  CAS  PubMed  Google Scholar 

DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22:1137–50. https://doi.org/10.1097/MIB.0000000000000750.

Article  PubMed  Google Scholar 

Pisani A, Rausch P, Bang C, et al. Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission. Microbiol Spectr. 2022;10:e00616–22. https://doi.org/10.1128/spectrum.00616-22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leeming ER, Johnson AJ, Spector TD, Le Roy CI. Effect of diet on the gut microbiota: rethinking intervention duration. Nutrients. 2019;11:2862. https://doi.org/10.3390/nu11122862.

Article  PubMed  PubMed Central  Google Scholar 

Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–30. https://doi.org/10.1038/nature11550.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan I, Ullah N, Zha L, et al. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD Treatment targeting the gut microbiome. Pathogens. 2019;8:126. https://doi.org/10.3390/pathogens8030126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garavaglia B, Vallino L, Amoruso A, Pane M, Ferraresi A, Isidoro C. The role of gut microbiota, immune system, and autophagy in the pathogenesis of inflammatory bowel disease: molecular mechanisms and therapeutic approaches. Asp Mol Med. 2024;4: 100056. https://doi.org/10.1016/j.amolm.2024.100056.

Article  Google Scholar 

Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158:1450–61. https://doi.org/10.1053/j.gastro.2020.01.006.

Article  PubMed  Google Scholar 

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517. https://doi.org/10.1038/ajg.2018.27.

Article  PubMed  Google Scholar 

Cushing K, Higgins PDR. Management of Crohn disease. JAMA. 2021;325:69–80. https://doi.org/10.1001/jama.2020.18936.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monstad IL, Solberg IC, Cvancarova M, et al. Outcome of ulcerative colitis 20 years after diagnosis in a prospective population-based inception cohort from South-Eastern Norway, the IBSEN study. J Crohns Colitis. 2020;15:969–79. https://doi.org/10.1093/ecco-jcc/jjaa232.

Article  PubMed Central  Google Scholar 

Limsrivilai J, Saleh ZM, Johnson LA, et al. Prevalence and effect of intestinal infections detected by a PCR-based stool test in patients with inflammatory bowel disease. Dig Dis Sci. 2020;65:3287–96. https://doi.org/10.1007/s10620-020-06071-2.

Article  CAS  PubMed  Google Scholar 

Samman AA, Alfares M, Bajabur RA, et al. Prevalence and risk factors of Clostridium difficile Infection among patients hospitalized for a flare of inflammatory bowel disease in King Abdulaziz University Hospital. Cureus. 2023;15:e48451. https://doi.org/10.7759/cureus.48451.

Article  PubMed  PubMed Central  Google Scholar 

Hernandez OL, Suarez ZK, Nagi T, Vallejo C, Ferris A. Dormant Crohn’s disease reactivated by Clostridioides difficile infection. Cureus. 2023;15:e37062. https://doi.org/10.7759/cureus.37062.

Article  PubMed  PubMed Central  Google Scholar 

Del Vecchio LE, Fiorani M, Tohumcu E, et al. Risk factors, diagnosis, and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Microorganisms. 2022;10:1315. https://doi.org/10.3390/microorganisms10071315.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanada Y, Khanna S, Loftus EV, Raffals LE, Pardi DS. Non-Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2018;16:528–33. https://doi.org/10.1016/j.cgh.2017.10.008.

Article  Google Scholar 

Hong S, Zaki TA, Main M, et al. Comparative evaluation of conventional stool testing and multiplex molecular panel in outpatients with relapse of inflammatory bowel disease. Inflamm Bowel Dis. 2021;27:1634–40. https://doi.org/10.1093/ibd/izaa336.

Article  PubMed  PubMed Central  Google Scholar 

Ramakrishnan B, Gopalakrishnan R, Senthur Nambi P, et al. Utility of multiplex polymerase chain reaction (PCR) in diarrhea—an Indian perspective. Indian J Gastroenterol. 2018;37:402–9. https://doi.org/10.1007/s12664-018-0889-y.

Article  PubMed  Google Scholar 

Borst A, Box ATA, Fluit AC. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis. 2004;23:289–99. https://doi.org/10.1007/s10096-004-1100-1.

Article  CAS  PubMed  Google Scholar 

Beal SG, Tremblay EE, Toffel S, Velez L, Rand KH. A Gastrointestinal PCR panel improves clinical management and lowers health care costs. J Clin Microbiol. 2017;56:e01457-17. https://doi.org/10.1128/JCM.01457-17.

Article  PubMed  PubMed Central  Google Scholar 

Freeman K, Mistry H, Tsertsvadze A, et al. Health economic methods and results. In: Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis. NIHR Journals Library; 2017. https://www.ncbi.nlm.nih.gov/books/NBK436122/. Accessed 6 May 2025.

Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Ther Adv Gastroenterol. 2021;14:17562848211004492. https://doi.org/10.1177/17562848211004493.

Article  CAS  Google Scholar 

Axelrad JE, Chen Z, Devlin J, Ruggles KV, Cadwell K. Pathogen-specific alterations in the gut microbiota predict outcomes in flare of inflammatory bowel disease complicated by gastrointestinal infection. Clin Transl Gastroenterol. 2023;14:e00550. https://doi.org/10.14309/ctg.0000000000000550.

Article  PubMed  Google Scholar 

Dimopoulos-Verma A, Hong S, Axelrad JE. Enteric infection at flare of inflammatory bowel disease impacts outcomes at 2 years. Inflamm Bowel Dis. 2024;30:1759–66. https://doi.org/10.1093/ibd/izad253.

Article  PubMed  Google Scholar 

Ahmad W, Nguyen NH, Boland BS, et al. Comparison of multiplex gastrointestinal pathogen panel and conventional stool testing for evaluation of diarrhea in patients with inflammatory bowel diseases. Dig Dis Sci. 2019;64:382–90. https://doi.org/10.1007/s10620-018-5330-y.

Article  PubMed  Google Scholar 

Axelrad JE, Joelson A, Green PHR, et al. Enteric infections are common in patients with flares of inflammatory bowel disease. Am J Gastroenterol. 2018;113:1530–9. https://doi.org/10.1038/s41395-018-0211-8.

Article  PubMed  PubMed Central  Google Scholar 

Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms. 2021;9:697. https://doi.org/10.3390/microorganisms9040697.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petersen AM. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases. APMIS. 2022;130:1–38. https://doi.org/10.1111/apm.13256.

Article  CAS  PubMed  PubMed Central